Cleerly LABS vs CT Cardiomegaly

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Cleerly LABS

by Cleerly

CT Cardiomegaly

by Innolitics

AI Verdict

Cleerly LABS provides a comprehensive analysis of coronary CT angiography (CCTA) for detailed plaque assessment and stenosis detection, aiming to manage coronary artery disease. In contrast, Innolitics' CT Cardiomegaly focuses on automatically measuring the cardiothoracic ratio from general CT chest images to assist in detecting cardiomegaly. While both are FDA-cleared cardiology AI tools utilizing CT, they address different clinical questions and provide distinct types of diagnostic information.

Choose Cleerly LABS if…

Choose Cleerly LABS if you require a comprehensive, AI-powered analysis of coronary CT angiography (CCTA) to precisely quantify and characterize atherosclerosis, stenosis, and ischemia. This tool is ideal for clinicians seeking detailed insights into plaque burden and type, enabling personalized heart disease management and tracking disease progression over time.

View Cleerly LABS →

Choose CT Cardiomegaly if…

Choose Innolitics' CT Cardiomegaly if your primary need is an automated, quantitative measurement of the cardiothoracic ratio from standard CT chest images. This command-line software is best suited for rapidly assisting in the detection of cardiomegaly, providing objective data for initial screening or assessment of heart enlargement.

View CT Cardiomegaly →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Cleerly LABS	CT Cardiomegaly
Pricing	Per analysis	Contact for pricing
Deployment	Cloud-based (AWS), web-based application, with on-site Cleerly Proxy for data transfer.	Docker Container (Ubuntu 20.04), command-line software
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Yes AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Cleerly LABS

Cleerly LABS (Tool A) is a web-based application with 3D visualization and integration capabilities, suggesting a user-friendly graphical interface for clinicians. In contrast, CT Cardiomegaly (Tool B) is a command-line software deployed as a Docker container, which typically requires more technical expertise and offers a less intuitive user experience.

Clinical Value

Cleerly LABS

Cleerly LABS (Tool A) offers a comprehensive analysis of CCTA, including detailed plaque assessment, stenosis quantification, ischemia detection, and tracking disease progression, providing deep insights for personalized heart disease management. CT Cardiomegaly (Tool B) focuses on a single quantitative measurement of cardiothoracic ratio for cardiomegaly detection, which is valuable but less extensive in its clinical scope.

Pricing & Value

Tie

Cleerly LABS (Tool A) provides clear pricing information, though it can be costly and often out-of-pocket for patients. CT Cardiomegaly (Tool B) requires contacting the vendor for pricing, making a direct comparison of value difficult due to a lack of transparency.

Enterprise Readiness

Cleerly LABS

Cleerly LABS (Tool A) is a cloud-based, web application with explicit integration capabilities for PACS, RIS, and EHR via a proxy, indicating a more streamlined and scalable solution for enterprise deployment. CT Cardiomegaly (Tool B), as a command-line Docker container, may require more specialized IT infrastructure and integration effort for broad enterprise adoption.

Innovation

Cleerly LABS

Cleerly LABS (Tool A) demonstrates higher innovation by providing comprehensive, AI-powered characterization of coronary atherosclerosis, including plaque volume, type, and progression tracking, which goes beyond traditional stenosis assessment. CT Cardiomegaly (Tool B) automates the measurement of the cardiothoracic ratio, a useful but less complex and established clinical metric.

Support & Docs

Tie

Neither the provided structured facts nor general knowledge about these specific products offer sufficient detail regarding their support services or documentation. Therefore, it is not possible to distinguish between the two tools on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Cleerly LABS	CT Cardiomegaly
Tool Name	Cleerly LABS	CT Cardiomegaly
Company	Cleerly	Innolitics
Primary Analysis Target	Coronary CT angiography (CCTA)	CT chest images
Key Measurement/Output	Comprehensive coronary plaque assessment (volume, type), stenosis detection and quantification	Automatic cardiothoracic ratio measurement (linear and area-based)
Additional Key Feature	3D visualization of coronary arteries, tracking disease progression over time	Outputs PDF and JSON reports

Videos

Demos, reviews, and walkthroughs featuring Cleerly LABS and CT Cardiomegaly.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications and diagnostic capabilities of Cleerly LABS versus CT Cardiomegaly?

Cleerly LABS is an AI-powered, FDA-cleared web-based software for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. In contrast, Innolitics' CT Cardiomegaly is an FDA-cleared AI-powered command-line software that automatically measures the cardiothoracic ratio from CT chest images, primarily assisting physicians in cardiomegaly detection with quantitative data.

What specific imaging data do these tools utilize, and what are their respective outputs?

Cleerly LABS analyzes coronary CT angiography (CCTA) images to provide comprehensive coronary plaque assessment (volume, type), stenosis detection and quantification, and 3D visualization of coronary arteries, with an optional module for ischemia detection. CT Cardiomegaly processes CT chest images to automatically calculate linear and area-based cardiothoracic ratios, outputting PDF and JSON reports.

What are the pricing structures and typical costs associated with using each tool?

Cleerly LABS is priced per analysis, with a retail price of $1500, currently offered at a discounted rate of $750, not including the separate CCTA scan cost, often resulting in a total out-of-pocket cost of $1000-$1500. For CT Cardiomegaly, pricing information requires direct contact with the vendor.

How do these tools contribute to tracking disease progression or assessing personalized risk?

Cleerly LABS offers personalized heart disease risk assessment and the ability to track disease progression over time through its comprehensive plaque assessment and stenosis analysis from CCTA. CT Cardiomegaly focuses on providing an automated cardiothoracic ratio measurement, which can be a marker for heart disease, but its primary function is not longitudinal disease tracking or personalized risk assessment beyond cardiomegaly detection.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Cleerly LABS or CT Cardiomegaly

Backers

Who funded each tool's parent company.